Musashi 2 regulates normal hematopoiesis and accelerates leukemogenesis

ChEBI2010-07-21 更新2026-07-21 收录

造血调控

白血病分子病理学

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-22778 数据链接链接失效反馈

官方服务：

资源简介：

Musashi 2 regulates normal hematopoiesis and accelerates leukemogenesis

创建时间：

2010-07-21

SCL establishes a global repressive environment and cooperates with Polycomb RYBP-PRC1 to suppress alternative lineages in blood-fated cells [ChIP-seq]

造血调控

表观遗传学

Understanding the molecular basis of cell fate decision is critical to shed light onto biological processes supporting tissue formation. In particular, whether lineage-fated cells derive from multi-pr

NIAID Data Ecosystem30

Functional and Physical Interactions between AML1 Proteins and an ETS Protein, MEF: Implications for the Pathogenesis of t(8;21)-Positive Leukemias

白血病分子病理学

转录因子互作

The AML1 and ETS families of transcription factors play critical roles in hematopoiesis; AML1, and its non-DNA-binding heterodimer partner CBFβ, are essential for the development of definitive hematop

PubMed Central20

Cryo-EM structure of the extracellular domain of murine Thrombopoietin Receptor in complex with Thrombopoietin.

结构生物学

造血调控

The haematopoietic cytokine thrombopoietin (Tpo) is the primary regulator of megakaryocyte and platelet numbers and is required for maintenance of the haematopoetic stem cell compartment. Tpo is a hea

NIAID Data Ecosystem10

PHF6 is a key regulator of normal human hematopoiesis by modulating NOTCH1 signaling activity

造血调控

Notch信号通路

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

NIAID Data Ecosystem30

MED16 negatively regulates erythropoiesis and myelopoiesis through modulation of chromatin accessibility. MED16 negatively regulates erythropoiesis and myelopoiesis through modulation of chromatin accessibility

造血调控

染色质可及性分析

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

NIAID Data Ecosystem20